32387-96-5

Basic information

• Product Name: 2,3-DIPHENYL-QUINOXALINE-6-CARBOXYLIC ACID
• Synonyms: 2,3-DIPHENYL-QUINOXALINE-6-CARBOXYLIC ACID;AKOS BBS-00001906;OTAVA-BB BB7216640853;Albb-008262;CAY10567;2,3-Diphenyl-6-carboxyquinoxaline;2,3-Diphenyl-6-quinoxalinecarboxylic Acid;BML-257
• CAS NO: 32387-96-5
• Molecular Formula: C₂₁H₁₄N₂O₂
• Molecular Weight: 326.35
• Product Categories: Heterocycles;Aromatics Compounds;Aromatics;Inhibitors
• Mol File: 32387-96-5.mol
• Article Data: 16

Chemical Properties

• Melting Point: 292-294°C
• Boiling Point: 493.4°Cat760mmHg
• Flash Point: 252.2°C
• Appearance: /
• Density: 1.289g/cm³
• Vapor Pressure: 1.5E-10mmHg at 25°C
• Refractive Index: 1.686
• Storage Temp.: -20°C Freezer
• Solubility: DMSO (Slightly), Tetrahydrofuran (Slightly)
• CAS DataBase Reference: 2,3-DIPHENYL-QUINOXALINE-6-CARBOXYLIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: 2,3-DIPHENYL-QUINOXALINE-6-CARBOXYLIC ACID(32387-96-5)
• EPA Substance Registry System: 2,3-DIPHENYL-QUINOXALINE-6-CARBOXYLIC ACID(32387-96-5)

Safety Data

• Hazard Codes: Xi
• HazardClass: IRRITANT
• Hazardous Substances Data: 32387-96-5(Hazardous Substances Data)

Usage

Description

2,3-DIPHENYL-QUINOXALINE-6-CARBOXYLIC ACID is an organic compound with a unique chemical structure, characterized by its greenish solid appearance. It possesses potential antineoplastic properties, making it a promising candidate for various applications in the pharmaceutical and medical industries.

Uses

Used in Pharmaceutical Industry:
2,3-DIPHENYL-QUINOXALINE-6-CARBOXYLIC ACID is used as a potential antineoplastic agent for its ability to target and inhibit the growth of cancer cells. Its chemical properties allow it to interfere with essential cellular processes, thereby exhibiting potential therapeutic effects against various types of cancer.
Used in Research and Development:
In the field of research and development, 2,3-DIPHENYL-QUINOXALINE-6-CARBOXYLIC ACID serves as a valuable compound for studying its antineoplastic properties and exploring its potential applications in the development of novel cancer treatments. Its unique chemical structure provides a foundation for further investigation and modification to enhance its efficacy and selectivity towards cancer cells.
Used in Drug Design and Synthesis:
2,3-DIPHENYL-QUINOXALINE-6-CARBOXYLIC ACID can be utilized as a key building block or starting material in the design and synthesis of new antineoplastic drugs. Its chemical properties and potential antineoplastic activity make it an attractive candidate for the development of innovative therapeutic agents targeting cancer cells.

InChI:InChI=1/C21H14N2O2/c24-21(25)16-11-12-17-18(13-16)23-20(15-9-5-2-6-10-15)19(22-17)14-7-3-1-4-8-14/h1-13H,(H,24,25)

Upstream product

• 134-81-6 benzil 
• 619-05-6 3,4-diaminobenzoic acid 

Downstream Products

• 935292-98-1 C₃₃H₂₆N₄O₃ 
• 835922-85-5 C₃₃H₂₆N₄O₄ 
• 32387-85-2 2,3-diphenyl-quinoxaline-6-carboxylic acid amide 

Relevant articles and documents

New quinoxalin-1,3,4-oxadiazole derivatives: Synthesis, characterization, in vitro biological evaluations, and molecular modeling studies

A new series of quinoxalin-1,3,4-oxadiazole (10a–l) derivatives was synthesized and evaluated against some metabolic enzymes including human carbonic anhydrase (hCA) isoenzymes I and II (carbonic anhydrases I and II), cholinesterase (acetylcholinesterase

Triketone compound containing quinoxaline structure, and preparation method and application thereof

The invention belongs to the technical field of medicine synthesis, and particularly relates to a triketone compound containing a quinoxaline structure, and a preparation method and an application thereof. The quinoxaline-containing triketone compound has a structure represented by general formula (I). The preparation method is mainly characterized in that a compound with a structure represented by formula (II) is contacted in the presence of an alkali and a solvent, and R1, R2, R3 and R4 in the formulas are respectively defined in the description. The quinoxaline-containing triketone compoundhas high herbicidal activity, and especially has an excellent effect of preventing and controlling broadleaf weeds and/or gramineous weeds, and the prevention and control effect is even better than that of some commercial herbicides sold in the market.

A NOVEL QUINOXALINE COMPOUND FOR ULTRAVIOLET ABSORBERS

PURPOSE: A novel quinoxaline compound, isomer thereof, precursor drug thereof, or pharmaceutically acceptable salt thereof is provided to absorb UVA and UVB. CONSTITUTION: A quinoxaline compound is denoted by chemical formula 1. An UV absorber or pharmaceutical or cosmetic composition for antiaging contains the quinoxaline compound, isomer thereof, precursor drug thereof, or pharmaceutically acceptable salt, hydrate, or solvate thereof as an active ingredient.